CRST Oy

Turku 20520

0 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease

Studies at this site

• A Study of Gantenerumab in Participants With Mild Alzheimer Disease — Completed
• A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease — Completed
• A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD). — Stopped early